Cerebrospinal Fluid p75 Neurotrophin Receptor Ectodomain Levels Across Clinically Diagnosed Alzheimer's Disease, Late-Life Depression, and Healthy Aging: A Preliminary Cross-Sectional Study.

Omori W, Kajitani N, Okada-Tsuchioka M, Takebayashi M

Open source

DOI
10.1002/npr2.70171
Published
2026 Sep
Container
Neuropsychopharmacology reports
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/npr2.70171,
  title = {Cerebrospinal Fluid p75 Neurotrophin Receptor Ectodomain Levels Across Clinically Diagnosed Alzheimer's Disease, Late-Life Depression, and Healthy Aging: A Preliminary Cross-Sectional Study.},
  author = {Omori W and Kajitani N and Okada-Tsuchioka M and Takebayashi M},
  year = {2026},
  journal = {Neuropsychopharmacology reports},
  doi = {10.1002/npr2.70171},
  url = {https://doi.org/10.1002/npr2.70171}
}

RIS

TY  - JOUR
TI  - Cerebrospinal Fluid p75 Neurotrophin Receptor Ectodomain Levels Across Clinically Diagnosed Alzheimer's Disease, Late-Life Depression, and Healthy Aging: A Preliminary Cross-Sectional Study.
AU  - Omori W
AU  - Kajitani N
AU  - Okada-Tsuchioka M
AU  - Takebayashi M
PY  - 2026
JO  - Neuropsychopharmacology reports
DO  - 10.1002/npr2.70171
UR  - https://doi.org/10.1002/npr2.70171
ER  - 

APA

W, O., N, K., M, O., & M, T. (2026). Cerebrospinal Fluid p75 Neurotrophin Receptor Ectodomain Levels Across Clinically Diagnosed Alzheimer's Disease, Late-Life Depression, and Healthy Aging: A Preliminary Cross-Sectional Study.. Neuropsychopharmacology reports. https://doi.org/10.1002/npr2.70171

Source records